# The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

> **NCT00724815** · PHASE3 · COMPLETED · sponsor: **NuPathe Inc.** · enrollment: 530 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** NP101 - Sumatriptan iontophoretic transdermal patch
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00724815
- **Lead sponsor:** NuPathe Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 530 (ACTUAL)
- **Last updated:** 2016-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00724815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00724815, "The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT00724815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*